For many years, the levels of serum and plasma amylase in patients have provided needed evidence for the diagnosis of acute pancreatitis. Early assay techniques were based on either a change in the absorption maxima of the complex between starch and iodine as the amylase degraded the starch; or a measurement of the increase in reducing groups as the starch was hydrolyzed by the amylase. These methods are not as reliable and easy to quantitate as spectrophotometric methods using a defined substrate.
Features and Benefits
- For the quantitative measurement of amylase (a1, 4-glucan-4-glucanohydrolase, E.C.220.127.116.11) activity in serum and plasma.
- One part, stable liquid; ready to use reagent. Easy to use, no additional reagent preparation required.
- Short reaction time with no lag phase. Faster throughput on automated analyzers.
- Excellent precision. Confidence in results.
- No significant interferences from triglyceride, glucose, ascorbic acid, bilirubin or hemoglobin. High reliability of testing and fewer re-tests.
|AMYLASE, DIRECT||80-5383-00||10x5 mL|